nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of the characteristics and prognosis of screen detected and symptomatic breast cancers
|
Sibbering, D.M. |
|
1993 |
2 |
3 |
p. 190- 1 p. |
artikel |
2 |
An immunohistochemical study of c-erbB-3 expression in breast cancer related to prognostic factors and survival
|
Quinn, C.M. |
|
1993 |
2 |
3 |
p. 191-192 2 p. |
artikel |
3 |
Anxiety and depression among patients with primary breast cancer
|
Jensen, A.B. |
|
1993 |
2 |
3 |
p. 197- 1 p. |
artikel |
4 |
A quantitative PCR assay for pNR-2/pS2 mRNA in breast cancer
|
Carr, M. |
|
1993 |
2 |
3 |
p. 192- 1 p. |
artikel |
5 |
A randomised trial of adjuvant versus neoadjuvant endocrine chemotherapy of operable breast cancer
|
Powles, T.J. |
|
1993 |
2 |
3 |
p. 187- 1 p. |
artikel |
6 |
A randomized clinical trial evaluating the duration of chemotherapy in patients with primary, node-positive breast cancer
|
Schumacher, M. |
|
1993 |
2 |
3 |
p. 194- 1 p. |
artikel |
7 |
A series of 11 patients with angiosarcoma of the breast
|
Salvadori, B. |
|
1993 |
2 |
3 |
p. 171-174 4 p. |
artikel |
8 |
Assessment of quality-of-life in the GBSG trial ‘breast preserving treatment in patients with early-stage breast cancer’
|
Olschewski, M. |
|
1993 |
2 |
3 |
p. 208- 1 p. |
artikel |
9 |
A staging system for patients with breast cancer metastases based on clinical prognostic factors
|
Walker, Q.J. |
|
1993 |
2 |
3 |
p. 154-159 6 p. |
artikel |
10 |
A survey of the opinions on ‘informed consent’ of women attending a breast unit
|
Maslin, A.M. |
|
1993 |
2 |
3 |
p. 208- 1 p. |
artikel |
11 |
Attempt at breast conserving treatment by primary chemotherapy
|
Weber, B. |
|
1993 |
2 |
3 |
p. 188- 1 p. |
artikel |
12 |
Bibliography of the Breast
|
|
|
1993 |
2 |
3 |
p. B17-B26 nvt p. |
artikel |
13 |
Breast cancer in BRAC1 gene carriers results in significantly better survival than in sporadic breast cancer
|
Porter, D.E. |
|
1993 |
2 |
3 |
p. 187- 1 p. |
artikel |
14 |
Breast screening and hormone replacement therapy: an unresolved question?
|
|
|
1993 |
2 |
3 |
p. 180-181 2 p. |
artikel |
15 |
Can the response of advanced breast cancer to successive chemotherapy regimens be predicted?
|
Twelves, C.J. |
|
1993 |
2 |
3 |
p. 204-205 2 p. |
artikel |
16 |
Clonality studies in multicentric breast cancer using P53 mutations and RNA polymorphisms
|
Feles, R. |
|
1993 |
2 |
3 |
p. 192- 1 p. |
artikel |
17 |
Colour doppler flow measurement to differentiate benign from malignant breast neoplasms
|
Holcombe, C. |
|
1993 |
2 |
3 |
p. 195-196 2 p. |
artikel |
18 |
Comparison of the effects of relaxation and befriending on anxiety reduction in breast cancer: some preliminary findings
|
Fox, W.P. |
|
1993 |
2 |
3 |
p. 200- 1 p. |
artikel |
19 |
Confirmation of a long-term prognostic index in breast cancer
|
Brown, J.M. |
|
1993 |
2 |
3 |
p. 144-147 4 p. |
artikel |
20 |
Conservative management of discrete benign breast lumps — A safe policy?
|
Bhattacharyya, S. |
|
1993 |
2 |
3 |
p. 195- 1 p. |
artikel |
21 |
Continuous versus 6–8 chemotherapy courses with Epirubicin and Ifosfamide in advanced breast cancer
|
Becher, R. |
|
1993 |
2 |
3 |
p. 194-195 2 p. |
artikel |
22 |
Coping strategies and psychological morbidity in breast assessment clinics
|
Chen, C. |
|
1993 |
2 |
3 |
p. 200- 1 p. |
artikel |
23 |
Correlation of histological classification of the in situ component of infiltrating ductal, carcinoma of the breast with grade of tumour, biological features and prognosis
|
Millis, R.R. |
|
1993 |
2 |
3 |
p. 202- 1 p. |
artikel |
24 |
Delayed progression of bone metastases with bisphosphonate therapy: a randomised phase III trial with intravenous Aredia (pamidronate disodium) in breast cancer patients
|
Conte, P.F. |
|
1993 |
2 |
3 |
p. 202- 1 p. |
artikel |
25 |
Demonstration of a positive feedback loop of paracrine growth stimulation in a new co-culture model of breast cancer
|
Orr, D.J.A. |
|
1993 |
2 |
3 |
p. 138-143 6 p. |
artikel |
26 |
Detection of breast cancer micrometastases in axillary lymph nodes using the polymerase chain reaction (PCR)
|
Schoenfeld, A. |
|
1993 |
2 |
3 |
p. 205- 1 p. |
artikel |
27 |
Diary of events
|
|
|
1993 |
2 |
3 |
p. 183- 1 p. |
artikel |
28 |
Does detection of breast cancer by screening affect subsequent pscyhiatric morbidity?
|
Haddad, P. |
|
1993 |
2 |
3 |
p. 200-201 2 p. |
artikel |
29 |
Early diagnosis of familial breast cancer
|
Møller, P. |
|
1993 |
2 |
3 |
p. 189- 1 p. |
artikel |
30 |
Early experience in breast cancer screening: emphasis on development of protocols for triple assessment
|
Ellis, I.O. |
|
1993 |
2 |
3 |
p. 148-153 6 p. |
artikel |
31 |
Effect of proteinase inhibition on breast cancer cell, invasion
|
Stonelake, P.S. |
|
1993 |
2 |
3 |
p. 206-207 2 p. |
artikel |
32 |
Endothelial cell proliferation in human breast carcinoma
|
Fox, S.B. |
|
1993 |
2 |
3 |
p. 206- 1 p. |
artikel |
33 |
Evidence for involvement of the breast cancer 1 (BRCA1) gene in sporadic breast cancer
|
Wallace, M. |
|
1993 |
2 |
3 |
p. 187- 1 p. |
artikel |
34 |
Experience with a breast cancer family screening clinic
|
Smyth, E.H. |
|
1993 |
2 |
3 |
p. 189- 1 p. |
artikel |
35 |
Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer
|
Nathan, B. |
|
1993 |
2 |
3 |
p. 134-137 4 p. |
artikel |
36 |
Expression of the c-erbB-3 protein in human breast cancer cell lines
|
Rajkumar, T. |
|
1993 |
2 |
3 |
p. 191- 1 p. |
artikel |
37 |
Factors relating to the diagnosis, of breast cancer and their impact on early psychological adjustment
|
Hopwood, P. |
|
1993 |
2 |
3 |
p. 200- 1 p. |
artikel |
38 |
Flap recurrence following simple mastectomy: an audit
|
O'Rourke, S. |
|
1993 |
2 |
3 |
p. 202- 1 p. |
artikel |
39 |
High levels of uPA and PA1 are associated with highly angiogenic breast carcinomas
|
Fox, S.B. |
|
1993 |
2 |
3 |
p. 206- 1 p. |
artikel |
40 |
Histological factors predicting breast recurrence following breast conserving therapy
|
Dixon, J.M. |
|
1993 |
2 |
3 |
p. 197- 1 p. |
artikel |
41 |
Identification of women at high risk of breast cancer during attendance at NHSBSP
|
De Silva, D. |
|
1993 |
2 |
3 |
p. 189- 1 p. |
artikel |
42 |
Immediate reconstruction after radical mastetomy: our experience
|
Pagano, G. |
|
1993 |
2 |
3 |
p. 186- 1 p. |
artikel |
43 |
Immunohistochemical detection of cytokeratin 14, Type IV collagen and laminin in 100 cases (invasive) ductal carcinoma of no special type and correlation with histological grade
|
Aung, W. |
|
1993 |
2 |
3 |
p. 165-170 6 p. |
artikel |
44 |
Impact of fine needle aspiration biopsy, ultrasound and mammography on open biopsy rate for benign breast disease
|
Green, B. |
|
1993 |
2 |
3 |
p. 195- 1 p. |
artikel |
45 |
Induction of the metastatic phenotype in rat mammary benign tumour cells by the gene for p9Ka a novel calcium-binding protein
|
Barraclough, R. |
|
1993 |
2 |
3 |
p. 191- 1 p. |
artikel |
46 |
Influence of timing of surgery during menstrual, cycle on survival of premenopausal women with operable breast cancer
|
Stonelake, P.S. |
|
1993 |
2 |
3 |
p. 201-202 2 p. |
artikel |
47 |
Intensive chemotherapy according to Abeloff in high risk patients with breast cancer
|
Jakoubková, J. |
|
1993 |
2 |
3 |
p. 185- 1 p. |
artikel |
48 |
Intra-arterial chemotherapy (IACT) for advanced breast cancer
|
Lewis, W.G. |
|
1993 |
2 |
3 |
p. 188- 1 p. |
artikel |
49 |
Investigation of a novel pure antioestrogen in women with primary breast cancer
|
De Friend, D. |
|
1993 |
2 |
3 |
p. 199- 1 p. |
artikel |
50 |
Is there a role for CA 15-3 estimation at presentation or during follow-up in primary breast carcinoma?
|
O'Hanlon, D.M. |
|
1993 |
2 |
3 |
p. 194- 1 p. |
artikel |
51 |
‘Living with a lump’ — A survey of anxiety levels amongst elderly breast cancer patients treated by hormone therapy compared to those treated by surgery
|
Cannon, P.M. |
|
1993 |
2 |
3 |
p. 196- 1 p. |
artikel |
52 |
Mastectomy and immediate breast reconstruction: follow-up of 74 cases
|
Modena, S. |
|
1993 |
2 |
3 |
p. 186- 1 p. |
artikel |
53 |
Mastoplasty in conservative surgery
|
Pagano, G. |
|
1993 |
2 |
3 |
p. 186- 1 p. |
artikel |
54 |
Nitric oxide production by benign and malignant breast tissue
|
Miles, D.W. |
|
1993 |
2 |
3 |
p. 207- 1 p. |
artikel |
55 |
Non comparative multi centre open trial in patients with breast cancer and bone metastases to investigate the effect of apd (pamidronate) on bone healing, morbidity bone metabolism
|
Tyrrell, C.J. |
|
1993 |
2 |
3 |
p. 202-203 2 p. |
artikel |
56 |
Non-operation of discrete solid palpable breast lumps in women over 35 years of age is safe
|
Galea, M.H. |
|
1993 |
2 |
3 |
p. 196- 1 p. |
artikel |
57 |
Novel methods for axillary staging in breast cancer
|
Allan, S.M. |
|
1993 |
2 |
3 |
p. 205- 1 p. |
artikel |
58 |
Oestrogen receptor expression in tamoxifen resistant human breast cancer
|
Johnston, S.R.D. |
|
1993 |
2 |
3 |
p. 193- 1 p. |
artikel |
59 |
Oestrogen receptor expression is decreased by oestrogen in MCF-7 cells but increased by oestrogen in three other oestrogen responsive breast cancer cell lines
|
Clayton, S.J. |
|
1993 |
2 |
3 |
p. 192- 1 p. |
artikel |
60 |
Parathyroid hormone related protein — a possible role in prediction of bone metastases early results of a prospective study
|
Henderson, M.A. |
|
1993 |
2 |
3 |
p. 203- 1 p. |
artikel |
61 |
Parathyroid hormone-related protein: cytosol extraction in breast cancer and normal breast tissue
|
Bundred, M.J. |
|
1993 |
2 |
3 |
p. 203- 1 p. |
artikel |
62 |
Peri-operative adjuvant chemotherapy in breast cancer
|
Clahsen, P.C. |
|
1993 |
2 |
3 |
p. 194- 1 p. |
artikel |
63 |
Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor in patients with advanced breast cancer
|
O'Brien, M.E.R. |
|
1993 |
2 |
3 |
p. 185- 1 p. |
artikel |
64 |
Phenotypic drift does not happen but lots of interesting things do
|
Blamey, R.W. |
|
1993 |
2 |
3 |
p. 190- 1 p. |
artikel |
65 |
Potential oncosuppressor genes in breast
|
Imam, S.A. |
|
1993 |
2 |
3 |
p. 191- 1 p. |
artikel |
66 |
Predicting the risk of depression and anxiety in women with early breast cancer
|
Hopwood, P. |
|
1993 |
2 |
3 |
p. 196- 1 p. |
artikel |
67 |
Primary chemotherapy for locally advanced breast cancer — early results of a randomized trial and implications for breast conservation
|
Cannon, P.M. |
|
1993 |
2 |
3 |
p. 188-189 2 p. |
artikel |
68 |
Primary medical chemotherapy with continuous infusional 5-fu (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: a very active new regimen
|
Smith, I.E. |
|
1993 |
2 |
3 |
p. 188- 1 p. |
artikel |
69 |
Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a prospective trial
|
Ribeiro, G.G. |
|
1993 |
2 |
3 |
p. 197-198 2 p. |
artikel |
70 |
Prognostic factors: seeking a shaft of light or getting lost in the woods? — A personal view from Sherwood forest
|
Hawkins, R.A. |
|
1993 |
2 |
3 |
p. 125-129 5 p. |
artikel |
71 |
Psychological costs of breast screening
|
Walker, L.G. |
|
1993 |
2 |
3 |
p. 208- 1 p. |
artikel |
72 |
Quadrantectomy with or without radiotherapy in conservative treatment for breast cancer milan trial III
|
Greco, M. |
|
1993 |
2 |
3 |
p. 197- 1 p. |
artikel |
73 |
Radiotherapy for bone metastasis are single and multiple fractions equivalent?
|
Life, K. |
|
1993 |
2 |
3 |
p. 204- 1 p. |
artikel |
74 |
Randomised comparison of a 13 fraction schedule with a conventional 25 fraction schedule of radiotherapy after local excision of early breast cancer: preliminary analysis
|
Yarnold, J.R. |
|
1993 |
2 |
3 |
p. 201- 1 p. |
artikel |
75 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
|
Gill, P.G. |
|
1993 |
2 |
3 |
p. 198- 1 p. |
artikel |
76 |
Randomized trial or the selective aromatase inhibitor formestane (Lentaron®) versus tamoxifen as first-line hormonal therapy in postmenopausal patients with advanced breast cancer
|
Peréz-Carrion, R. |
|
1993 |
2 |
3 |
p. 198-199 2 p. |
artikel |
77 |
Reply
|
van Dalen, Arie |
|
1993 |
2 |
3 |
p. 182- 1 p. |
artikel |
78 |
re: Serum markers in breast cancer management
|
Gion, Massimo |
|
1993 |
2 |
3 |
p. 182- 1 p. |
artikel |
79 |
Residual disease in the conserved breast following surgery for mammogram-detected breast cancer
|
Macmillan, R.D. |
|
1993 |
2 |
3 |
p. 201- 1 p. |
artikel |
80 |
Results of first line endocrine therapy for advanced breast cancer in premenopausal women with skeletal metastases only
|
Jonat, W. |
|
1993 |
2 |
3 |
p. 203-204 2 p. |
artikel |
81 |
Safe criteria for breast conservation without radical excision
|
Sibbering, D.M. |
|
1993 |
2 |
3 |
p. 198- 1 p. |
artikel |
82 |
Salvage therapies in women failing first-line treatment with FEC (fluorouracil-epirubicin cyclophosphamide) for advanced breast cancer
|
Porkka, K. |
|
1993 |
2 |
3 |
p. 195- 1 p. |
artikel |
83 |
Screening for contralateral breast cancer — is it worthwhile?
|
Sibbering, D.M. |
|
1993 |
2 |
3 |
p. 190- 1 p. |
artikel |
84 |
Screening the at risk patient: family history
|
Sibbering, D.M. |
|
1993 |
2 |
3 |
p. 186-187 2 p. |
artikel |
85 |
Second line endocrine treatment of advanced breast cancer — a randomized cross-over study of medroxyprogesterone acetate and aminoglutethimide
|
Hultoborn, R. |
|
1993 |
2 |
3 |
p. 199- 1 p. |
artikel |
86 |
Secretion of TGFβ isoforms by breast tumour fibroblasts in vitro
|
Benson, J.R. |
|
1993 |
2 |
3 |
p. 207- 1 p. |
artikel |
87 |
Selection for adjuvant systemic therapy using the Nottingham prognostic index (NPI)
|
Morgan, D.A.L. |
|
1993 |
2 |
3 |
p. 206- 1 p. |
artikel |
88 |
Selection of optimal intensive induction chemotherapy preceding high-dose consolidation chemotherapy for advanced breast cancer and investigation of the optimal time for peripheral blood progenitor cell (PBSC) collection
|
Van Hoef, M.E.H.M. |
|
1993 |
2 |
3 |
p. 185-186 2 p. |
artikel |
89 |
Significance of phosphomonoesters in human breast cancer — an in vivo and in vitro 31-Phosphorus (31-P) magnetic resonance (MRS) study
|
Twelves, C.J. |
|
1993 |
2 |
3 |
p. 190-191 2 p. |
artikel |
90 |
Surgical aspects of the conservative treatment of large size breast cancer after primary chemotherapy
|
Zurrida, S. |
|
1993 |
2 |
3 |
p. 187-188 2 p. |
artikel |
91 |
The assessment of body image in women treated for cancer of the breast
|
Hopwood, P. |
|
1993 |
2 |
3 |
p. 196-197 2 p. |
artikel |
92 |
The contribution of full axillary dissection to a prognostic index
|
Walls, J. |
|
1993 |
2 |
3 |
p. 205-206 2 p. |
artikel |
93 |
The effect of parathyroid hormone related protein on 1,25(OH)2 vitamin D in patients with breast cancer
|
Walls, J. |
|
1993 |
2 |
3 |
p. 203- 1 p. |
artikel |
94 |
The evaluation of loading-doses of Medroxypregesterone acetate (MPA) with two different maintenance schedules in advanced breast cancer
|
Clinton, O. |
|
1993 |
2 |
3 |
p. 199- 1 p. |
artikel |
95 |
The growth hormone/insulin-like growth factor axis and breast cancer risk
|
Stoll, B.A. |
|
1993 |
2 |
3 |
p. 130-133 4 p. |
artikel |
96 |
The mammographic appearances of fibromatosis of the breast
|
Cornford, E.J. |
|
1993 |
2 |
3 |
p. 175-179 5 p. |
artikel |
97 |
The prognostic effect of histological tumour grade in node-negative breast cancer patients
|
Schumacher, M. |
|
1993 |
2 |
3 |
p. 205- 1 p. |
artikel |
98 |
The silent majority — meeting the emotional needs of women with a negative diagnosis — the results of a patient survey
|
Turnbull, N. |
|
1993 |
2 |
3 |
p. 201- 1 p. |
artikel |
99 |
The staging of breast cancer: a comparison of four staging systems in a cohort of 3800 patients
|
Kerr, G.R. |
|
1993 |
2 |
3 |
p. 160-164 5 p. |
artikel |
100 |
Tissue polypeptide specific antigen (TPS): a new serum marker of proliferative activity in breast cancer
|
Cannon, P.M. |
|
1993 |
2 |
3 |
p. 193- 1 p. |
artikel |
101 |
TPS in advanced breast cancer during palliative: systemic therapy with special reference to metastatic sites
|
Jönsson, P.I. |
|
1993 |
2 |
3 |
p. 193- 1 p. |
artikel |
102 |
Transforming growth factor beta secretion by human breast fibroblasts in vitro
|
van Roozendaal, C.E.P. |
|
1993 |
2 |
3 |
p. 207- 1 p. |
artikel |
103 |
Treatment of bone metastases by aromatase inhibition with 4OH Androstenedione in women with advanced breast cancer
|
Murray, R. |
|
1993 |
2 |
3 |
p. 204- 1 p. |
artikel |
104 |
Tumour markers in the measurement of therapy response in breast cancer
|
van Dalen, A. |
|
1993 |
2 |
3 |
p. 193- 1 p. |
artikel |